Fibrinogenopenia acute and abruptio plancentae our therapeutic approach

Descripción del Articulo

The author analyzes the criteria with which it has faced in his clinic consecutive acute syndrome fibrinogenopenia the box "placental abruption". Considers that addressed the causes of the decline in the levels of fibrinogen, is justified today than ever before proceeding to the early arti...

Descripción completa

Detalles Bibliográficos
Autor: García Valenzuela, Raúl
Formato: artículo
Fecha de Publicación:2015
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista Peruana de Ginecología y Obstetricia
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/727
Enlace del recurso:http://51.222.106.123/index.php/RPGO/article/view/727
Nivel de acceso:acceso abierto
id REVSPOG_482df1db350ce9ee49ea0e42904023d6
oai_identifier_str oai:ojs.pkp.sfu.ca:article/727
network_acronym_str REVSPOG
network_name_str Revista Peruana de Ginecología y Obstetricia
repository_id_str .
dc.title.none.fl_str_mv Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
Fibrinogenopenia aguda y abruptio plancentae nuestro criterio terapéutico
title Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
spellingShingle Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
García Valenzuela, Raúl
title_short Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
title_full Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
title_fullStr Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
title_full_unstemmed Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
title_sort Fibrinogenopenia acute and abruptio plancentae our therapeutic approach
dc.creator.none.fl_str_mv García Valenzuela, Raúl
author García Valenzuela, Raúl
author_facet García Valenzuela, Raúl
author_role author
description The author analyzes the criteria with which it has faced in his clinic consecutive acute syndrome fibrinogenopenia the box "placental abruption". Considers that addressed the causes of the decline in the levels of fibrinogen, is justified today than ever before proceeding to the early artificial rupture of membranes (medical birth Kreis) in order to trigger the job and also interfere with the release of tromboplásticas or fibrinolytic substances simultaneously and closely watching the changes taking place in the test and the clot fibrinogenemia curve. When treatment does not work obstetric results or blood incoagulability syndrome is emerging from a severe beginning with characters, I think that should be used without delay to the evacuation of the uterus by Cesarean section. Specific treatment of hypo- and afibrinogenaemia should include the timely administration - using the intravenous route - human fibrinogen. According to the experience of the Service, doses need not be as high as those that have been recommended by the American authors. Suffice generally 2 or 3 grams to reach critical levels (100 mg regimen. 0/100) and ensure coagulation. In addition they will be used generously blood and plasma transfusions, particularly when drugs are not available, as has happened in some cases that the author says. Given the high cost of treatment, recommended to administer the drug in cases of Caesarean section only after it has been evacuated uterus propitious moment to get the best results, deleted and the apparent root causes blood incoagulability box. It follows from the above that hysterectomy is a rare alternative (1 case in this series); when it is performed, rather it derives indications of contractile failure of the uterine muscle fiber. The author emphasizes that the results obtained in the course of the last five years in the 11 patients who had acute syndrome fibrinogenopenia and "placental abruption" - having the problem solved in 8 by the cesarean section - on a total of 138 cases, This represents a rate of 7.97%, have been good, if you think that the special mortality recorded was 9.09%, and that mortality in all the retroplacentarias bleeding (reached 1381 in the same period to 3.17%. The fetal stillbirth was very high, reaching 90.9%, while the overall rate casuistry that was recorded was only 63.4%.
publishDate 2015
dc.date.none.fl_str_mv 2015-05-31
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/727
url http://51.222.106.123/index.php/RPGO/article/view/727
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://51.222.106.123/index.php/RPGO/article/view/727/688
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
dc.source.none.fl_str_mv The Peruvian Journal of Gynecology and Obstetrics ; Vol. 8 No. 1-2 (1962); 36-43
Revista Peruana de Ginecología y Obstetricia; Vol. 8 Núm. 1-2 (1962); 36-43
2304-5132
2304-5124
reponame:Revista Peruana de Ginecología y Obstetricia
instname:Sociedad Peruana de Obstetricia y Ginecología
instacron:SPOG
instname_str Sociedad Peruana de Obstetricia y Ginecología
instacron_str SPOG
institution SPOG
reponame_str Revista Peruana de Ginecología y Obstetricia
collection Revista Peruana de Ginecología y Obstetricia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846516626771410944
spelling Fibrinogenopenia acute and abruptio plancentae our therapeutic approachFibrinogenopenia aguda y abruptio plancentae nuestro criterio terapéuticoGarcía Valenzuela, RaúlThe author analyzes the criteria with which it has faced in his clinic consecutive acute syndrome fibrinogenopenia the box "placental abruption". Considers that addressed the causes of the decline in the levels of fibrinogen, is justified today than ever before proceeding to the early artificial rupture of membranes (medical birth Kreis) in order to trigger the job and also interfere with the release of tromboplásticas or fibrinolytic substances simultaneously and closely watching the changes taking place in the test and the clot fibrinogenemia curve. When treatment does not work obstetric results or blood incoagulability syndrome is emerging from a severe beginning with characters, I think that should be used without delay to the evacuation of the uterus by Cesarean section. Specific treatment of hypo- and afibrinogenaemia should include the timely administration - using the intravenous route - human fibrinogen. According to the experience of the Service, doses need not be as high as those that have been recommended by the American authors. Suffice generally 2 or 3 grams to reach critical levels (100 mg regimen. 0/100) and ensure coagulation. In addition they will be used generously blood and plasma transfusions, particularly when drugs are not available, as has happened in some cases that the author says. Given the high cost of treatment, recommended to administer the drug in cases of Caesarean section only after it has been evacuated uterus propitious moment to get the best results, deleted and the apparent root causes blood incoagulability box. It follows from the above that hysterectomy is a rare alternative (1 case in this series); when it is performed, rather it derives indications of contractile failure of the uterine muscle fiber. The author emphasizes that the results obtained in the course of the last five years in the 11 patients who had acute syndrome fibrinogenopenia and "placental abruption" - having the problem solved in 8 by the cesarean section - on a total of 138 cases, This represents a rate of 7.97%, have been good, if you think that the special mortality recorded was 9.09%, and that mortality in all the retroplacentarias bleeding (reached 1381 in the same period to 3.17%. The fetal stillbirth was very high, reaching 90.9%, while the overall rate casuistry that was recorded was only 63.4%.El autor analiza el criterio con que se ha encarado en su Clínica el síndrome de fibrinogenopenia aguda consecutiva al cuadro de "abruptio placentae". Considera que atendidas las causas que originan el descenso de los niveles del fibrinógeno, se justifica hoy más que antes proceder a la rotura artificial precoz de las membranas (parto médico de Kreis), a fin de desencadenar el trabajo y a la vez interferir en la liberación de sustancias tromboplásticas o fibrinolíticas, observando simultáneamente y muy de cerca las variaciones que se operan en la prueba del coágulo y curva de fibrinogenemia. Cuando el tratamiento obstétrico no surte resultados o el síndrome de incoagulabilidad sanguínea se perfila desde, un comienzo con caracteres severos, estimo que debe recurrirse sin demora a la evacuación del útero mediante la operación cesárea. El tratamiento específico de la hipo y afibrinogenemia debería contemplar la administración oportuna - usando la vía endovenosa - de fibrinógeno humano. Conforme a la experiencia del Servicio, las dosis no necesitan ser tan altas como las que han sido preconizadas por los autores norteamericanos. Bastan en general 2 o 3 gramos para alcanzar los niveles críticos (100 mgrs. 0/100) y asegurar la coagulación. Además se utilizarán con generosidad transfusiones de sangre y plasma, particularmente cuando no se disponga de droga, como ha sucedido en algunos de los casos que el autor comenta. En atención al alto costo de tratamiento, recomienda administrar la droga en los casos de operación cesárea sólo una vez que ha sido evacuado el útero, momento propicio para obtener los mejores resultados, suprimidos ya las causas aparentes que originan el cuadro de incoagulabilidad sanguínea. Se infiere de lo anterior que la histerectomía representa una alternativa poco común (1 caso en esta serie); cuando se la practica, su indicación dimana más bien de la insuficiencia contráctil de la fibra muscular uterina. El autor recalca que los resultados obtenidos en el curso de los últimos 5 años en las 11 pacientes que presentaron el síndrome de fibrinogenopenia aguda y "abruptio placentae” - habiéndose resuelto en 8 el problema mediante lo operación cesárea - sobre un total de 138 casos, lo que representa una frecuencia de 7.97%, han sido buenos, si se piensa que la mortalidad especial que se registró fue de 9.09%, siendo que la mortalidad en el conjunto de las hemorragias retroplacentarias (1381 alcanzó en el mismo período a 3.17%. La mortinatalidad fetal fue muy alta, llegando a 90.9%, mientras que en la casuística global la tasa que se consignó fue tan sólo de 63.4 %.Sociedad Peruana de Obstetricia y Ginecología2015-05-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://51.222.106.123/index.php/RPGO/article/view/727The Peruvian Journal of Gynecology and Obstetrics ; Vol. 8 No. 1-2 (1962); 36-43Revista Peruana de Ginecología y Obstetricia; Vol. 8 Núm. 1-2 (1962); 36-432304-51322304-5124reponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttp://51.222.106.123/index.php/RPGO/article/view/727/688info:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/7272015-07-21T17:55:46Z
score 12.884314
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).